Corneal Toxicity After Stinging by a Sea Anemone, Anthopleura uchidai: A Case Report With Confirmation by In Vitro Study.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
01 Aug 2022
Historique:
received: 22 05 2021
accepted: 18 06 2021
entrez: 13 7 2022
pubmed: 14 7 2022
medline: 16 7 2022
Statut: ppublish

Résumé

This study aimed to present a case of transient corneal damage after exposure to the effluent squirting from a sea anemone, Anthopleura uchidai, and to experimentally confirm the presence of toxic substances from an A. uchidai in the tissue culture. We reviewed the clinical course of a 51-year-old man who complained of decreased vision in his left eye after the stinging of a sea anemone, A. uchidai. The toxicity of the effluents from an A. uchidai in immortalized human corneal endothelial cells (HCEnC-21T) and human corneal epithelial cells in vitro were evaluated. Corneal edema was observed, and his best-corrected visual acuity was 0.2. Corneal endothelial cell density decreased to 1435 cells/mm2. Although his corneal edema and visual acuity recovered after topical instillation with a topical steroid and 5% NaCl, corneal endothelial cell density did not recover for 3 years after the injury. The in vitro study revealed fractioned effluence from the sea anemone, by size-exclusion chromatography, containing a substance toxic to HCEnC-21T with cytoplasmic swelling and nuclear dislocation. It is necessary to be cautious of effluents from sea anemones along the coast, and ophthalmologists should be aware that sea anemones can cause corneal endothelial dysfunction.

Identifiants

pubmed: 35830581
doi: 10.1097/ICO.0000000000002842
pii: 00003226-202208000-00017
doi:

Types de publication

Case Reports Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1035-1037

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors have no funding or conflicts of interest to disclose.

Références

Honma T, Shiomi K. Peptide toxins in sea anemones: structural and functional aspects. Mar Biotechnol (NY). 2006;8:1–10.
Massmanian A, Valcuende Cavero F, Ramirez Bosca A, et al. Sea anemone dermatitis. Contact Dermatitis. 1988;18:169–170.
Mizuno M, Ito Y, Morgan BP. Exploiting the nephrotoxic effects of venom from the sea anemone, Phyllodiscus semoni, to create a hemolytic uremic syndrome model in the rat. Mar Drugs. 2012;10:1582–1604.
Mizuno M, Nishikawa K, Yuzawa Y, et al. Acute renal failure after a sea anemone sting. Am J Kidney Dis. 2000;36:E10.
Subiza J, Kilimajer J, Barjau C, et al. Occupational asthma caused by Actinia equina. J Investig Allergol Clin Immunol. 2018;28:277–278.
Nagata K, Hide M, Tanaka T, et al. Anaphylactic shock caused by exposure to sea anemones. Allergol Int. 2006;55:181–184.
Schmedt T, Chen Y, Nguyen TT, et al. Telomerase immortalization of human corneal endothelial cells yields functional hexagonal monolayers. PLoS One. 2012;7:e51427.
Shiomi K, Honma T, Ide M, et al. An epidermal growth factor-like toxin and two sodium channel toxins from the sea anemone Stichodactyla gigantea. Toxicon. 2003;41:229–236.
Honma T, Kawahata S, Ishida M, et al. Novel peptide toxins from the sea anemone Stichodactyla haddoni. Peptides. 2008;29:536–544.

Auteurs

Takashi Ono (T)

Department of Ophthalmology, Miyata Eye Hospital, Miyazaki, Japan.
Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Takuya Iwasaki (T)

Department of Ophthalmology, Miyata Eye Hospital, Miyazaki, Japan.

Yukiko Terada (Y)

Department of Ophthalmology, Miyata Eye Hospital, Miyazaki, Japan.
Department of Ophthalmology, Tokyo Metropolitan Geriatric Medical Center, Tokyo, Japan ; and.

Takashi Miyai (T)

Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Yosai Mori (Y)

Department of Ophthalmology, Miyata Eye Hospital, Miyazaki, Japan.

Ryohei Nejima (R)

Department of Ophthalmology, Miyata Eye Hospital, Miyazaki, Japan.

Tomohiro Honma (T)

Department of Marine Biology and Sciences, Tokai University, Sapporo, Japan .

Makoto Aihara (M)

Department of Ophthalmology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Kazunori Miyata (K)

Department of Ophthalmology, Miyata Eye Hospital, Miyazaki, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH